Chk1/ 2 inhibition enhances response to lurbinectedin treatment in small cell lung cancer

被引：1
|
作者：
Uruchurtu, Ashley Sanchez Sevilla
Roady, Tyler
Anderson, Agenxnie
El-Deiry, Wafik S.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3191
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Chk1 inhibition: a promising targeted treatment for head and neck squamous cell carcinoma
    van Harten, Anne M.
    Stigter-van Walsum, Marijke
    Buijze, Marijke
    Braakhuis, Boudewijn Jm
    Brakenhoff, Ruud H.
    CANCER RESEARCH, 2016, 76
  • [22] FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
    Singh, Sonia
    Jaigirdar, Adnan A.
    Mulkey, Flora
    Cheng, Joyce
    Hamed, Salaheldin S.
    Li, Yangbing
    Liu, Jiang
    Zhao, Hong
    Goheer, Anwar
    Helms, Whitney S.
    Wang, Xing
    Agarwal, Rajiv
    Pragani, Rajan
    Korsah, Kwadwo
    Tang, Shenghui
    Leighton, John
    Rahman, Atiqur
    Beaver, Julia A.
    Pazdur, Richard
    Theoret, Marc R.
    Singh, Harpreet
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2378 - 2382
  • [23] Roles of Chk1 in cell biology and cancer therapy
    Zhang, Youwei
    Hunter, Tony
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (05) : 1013 - 1023
  • [24] Alterations of Chk1 and Chk2 expression in colon cancer
    Stawinska, Magdalena
    Cygankiewicz, Adam
    Trzcinski, Radzislaw
    Mik, Michal
    Dziki, Adam
    Krajewska, Wanda M.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (12) : 1243 - 1249
  • [25] Alterations of Chk1 and Chk2 expression in colon cancer
    Magdalena Stawinska
    Adam Cygankiewicz
    Radzislaw Trzcinski
    Michal Mik
    Adam Dziki
    Wanda M. Krajewska
    International Journal of Colorectal Disease, 2008, 23 : 1243 - 1249
  • [26] Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation
    Zhao, Xiaoliang
    Kim, In-Kyu
    Kallakury, Bhaskar
    Chahine, Joeffrey J.
    Iwama, Eiji
    Pierobon, Mariaelena
    Petricoin, Emanuel
    McCutcheon, Justine N.
    Zhang, Yu-Wen
    Umemura, Shigeki
    Chen, Vincent
    Wang, Changli
    Giaccone, Giuseppe
    MOLECULAR ONCOLOGY, 2021, 15 (04) : 1130 - 1145
  • [27] HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
    Moses, Niko
    Zhang, Mu
    Wu, Jheng-Yu
    Hu, Chen
    Xiang, Shengyan
    Geng, Xinran
    Chen, Yue
    Bai, Wenlong
    Zhang, You-Wei
    Bepler, Gerold
    Zhang, Xiaohong Mary
    CELLS, 2020, 9 (10)
  • [28] Chk1 and Chk2 kinases in checkpoint control and cancer
    Bartek, J
    Lukas, J
    CANCER CELL, 2003, 3 (05) : 421 - 429
  • [29] Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma
    Zeng, Ling
    Beggs, Reena R.
    Cooper, Tiffiny S.
    Weaver, Alice N.
    Yang, Eddy S.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (04) : 591 - 600
  • [30] Combining Chk1/2 Inhibition With Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma
    Yang, E. S.
    Zeng, L.
    Beggs, R.
    Cooper, T.
    Weaver, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S148 - S149
12345